<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-04-29" modified="2020-10-07" version="157">
<accession>Q96P31</accession>
<accession>A0N0M4</accession>
<accession>A8MTH7</accession>
<accession>D3DVD2</accession>
<accession>Q5VXZ8</accession>
<accession>Q8N6S2</accession>
<accession>Q96LA4</accession>
<accession>Q96P27</accession>
<accession>Q96P28</accession>
<accession>Q96P29</accession>
<accession>Q96P30</accession>
<name>FCRL3_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="30">Fc receptor-like protein 3</fullName>
<shortName evidence="30">FcR-like protein 3</shortName>
<shortName evidence="30">FcRL3</shortName>
</recommendedName>
<alternativeName>
<fullName evidence="30">Fc receptor homolog 3</fullName>
<shortName evidence="30">FcRH3</shortName>
</alternativeName>
<alternativeName>
<fullName>IFGP family protein 3</fullName>
<shortName>hIFGP3</shortName>
</alternativeName>
<alternativeName>
<fullName>Immune receptor translocation-associated protein 3</fullName>
</alternativeName>
<alternativeName>
<fullName>SH2 domain-containing phosphatase anchor protein 2</fullName>
</alternativeName>
<cdAntigenName>CD307c</cdAntigenName>
</protein>
<gene>
<name type="primary" evidence="32">FCRL3</name>
<name type="synonym" evidence="32">FCRH3</name>
<name type="synonym" evidence="32">IFGP3</name>
<name type="synonym" evidence="32">IRTA3</name>
<name type="synonym" evidence="32">SPAP2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="9772" last="9777">
<title>Identification of a family of Fc receptor homologs with preferential B cell expression.</title>
<authorList>
<person name="Davis R.S."/>
<person name="Wang Y.-H."/>
<person name="Kubagawa H."/>
<person name="Cooper M.D."/>
</authorList>
<dbReference type="PubMed" id="11493702"/>
<dbReference type="DOI" id="10.1073/pnas.171308498"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Lymph node</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2002" name="Biochem. Biophys. Res. Commun." volume="293" first="1037" last="1046">
<title>SPAP2, an Ig family receptor containing both ITIMs and ITAMs.</title>
<authorList>
<person name="Xu M.-J."/>
<person name="Zhao R."/>
<person name="Cao H."/>
<person name="Zhao Z.J."/>
</authorList>
<dbReference type="PubMed" id="12051764"/>
<dbReference type="DOI" id="10.1016/s0006-291x(02)00332-7"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4 AND 5)</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH PTPN6; PTPN11; SYK AND ZAP70</scope>
<scope>MUTAGENESIS OF TYR-650; TYR-662; TYR-692 AND TYR-722</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="3">
<citation type="submission" date="2006-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Livingston R.J."/>
<person name="Shaffer T."/>
<person name="McFarland I."/>
<person name="Nguyen C.P."/>
<person name="Stanaway I.B."/>
<person name="Rajkumar N."/>
<person name="Johnson E.J."/>
<person name="da Ponte S.H."/>
<person name="Willa H."/>
<person name="Ahearn M.O."/>
<person name="Bertucci C."/>
<person name="Acklestad J."/>
<person name="Carroll A."/>
<person name="Swanson J."/>
<person name="Gildersleeve H.I."/>
<person name="Nickerson D.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1)</scope>
<scope>VARIANT ASP-28</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<scope>VARIANT ASP-28</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6)</scope>
<source>
<tissue>Lymph</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="2002" name="Blood" volume="99" first="2662" last="2669">
<title>IRTAs: a new family of immunoglobulin-like receptors differentially expressed in B cells.</title>
<authorList>
<person name="Miller I."/>
<person name="Hatzivassiliou G."/>
<person name="Cattoretti G."/>
<person name="Mendelsohn C."/>
<person name="Dalla-Favera R."/>
</authorList>
<dbReference type="PubMed" id="11929751"/>
<dbReference type="DOI" id="10.1182/blood.v99.8.2662"/>
</citation>
<scope>CHARACTERIZATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2005" name="Nat. Genet." volume="37" first="478" last="485">
<title>A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.</title>
<authorList>
<person name="Kochi Y."/>
<person name="Yamada R."/>
<person name="Suzuki A."/>
<person name="Harley J.B."/>
<person name="Shirasawa S."/>
<person name="Sawada T."/>
<person name="Bae S.-C."/>
<person name="Tokuhiro S."/>
<person name="Chang X."/>
<person name="Sekine A."/>
<person name="Takahashi A."/>
<person name="Tsunoda T."/>
<person name="Ohnishi Y."/>
<person name="Kaufman K.M."/>
<person name="Kang C.P."/>
<person name="Kang C."/>
<person name="Otsubo S."/>
<person name="Yumura W."/>
<person name="Mimori A."/>
<person name="Koike T."/>
<person name="Nakamura Y."/>
<person name="Sasazuki T."/>
<person name="Yamamoto K."/>
</authorList>
<dbReference type="PubMed" id="15838509"/>
<dbReference type="DOI" id="10.1038/ng1540"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS AND GRAVES DISEASE</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Ann. Rheum. Dis." volume="65" first="671" last="673">
<title>Supportive evidence for a genetic association of the FCRL3 promoter polymorphism with rheumatoid arthritis.</title>
<authorList>
<person name="Ikari K."/>
<person name="Momohara S."/>
<person name="Nakamura T."/>
<person name="Hara M."/>
<person name="Yamanaka H."/>
<person name="Tomatsu T."/>
<person name="Kamatani N."/>
</authorList>
<dbReference type="PubMed" id="16176992"/>
<dbReference type="DOI" id="10.1136/ard.2005.043489"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Ann. Rheum. Dis." volume="65" first="1188" last="1191">
<title>Epistatic interaction between FCRL3 and NFkappaB1 genes in Spanish patients with rheumatoid arthritis.</title>
<authorList>
<person name="Martinez A."/>
<person name="Sanchez E."/>
<person name="Valdivia A."/>
<person name="Orozco G."/>
<person name="Lopez-Nevot M.A."/>
<person name="Pascual-Salcedo D."/>
<person name="Balsa A."/>
<person name="Fernandez-Gutierrez B."/>
<person name="de la Concha E.G."/>
<person name="Garcia-Sanchez A."/>
<person name="Koeleman B.P.C."/>
<person name="Urcelay E."/>
<person name="Martin J."/>
</authorList>
<dbReference type="PubMed" id="16476711"/>
<dbReference type="DOI" id="10.1136/ard.2005.048454"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2006" name="Arthritis Res. Ther." volume="8" first="R117" last="R117">
<title>Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?</title>
<authorList>
<person name="Eyre S."/>
<person name="Bowes J."/>
<person name="Potter C."/>
<person name="Worthington J."/>
<person name="Barton A."/>
</authorList>
<dbReference type="PubMed" id="16859508"/>
<dbReference type="DOI" id="10.1186/ar2006"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Arthritis Rheum." volume="54" first="3820" last="3827">
<title>Rheumatoid arthritis association with the FCRL3 -169C polymorphism is restricted to PTPN22 1858T-homozygous individuals in a Canadian population.</title>
<authorList>
<person name="Newman W.G."/>
<person name="Zhang Q."/>
<person name="Liu X."/>
<person name="Walker E."/>
<person name="Ternan H."/>
<person name="Owen J."/>
<person name="Johnson B."/>
<person name="Greer W."/>
<person name="Mosher D.P."/>
<person name="Maksymowych W.P."/>
<person name="Bykerk V.P."/>
<person name="Keystone E.C."/>
<person name="Amos C.I."/>
<person name="Siminovitch K.A."/>
</authorList>
<dbReference type="PubMed" id="17133579"/>
<dbReference type="DOI" id="10.1002/art.22270"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Int. Immunol." volume="18" first="1363" last="1373">
<title>Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia.</title>
<authorList>
<person name="Polson A.G."/>
<person name="Zheng B."/>
<person name="Elkins K."/>
<person name="Chang W."/>
<person name="Du C."/>
<person name="Dowd P."/>
<person name="Yen L."/>
<person name="Tan C."/>
<person name="Hongo J.-A."/>
<person name="Koeppen H."/>
<person name="Ebens A."/>
</authorList>
<dbReference type="PubMed" id="16849395"/>
<dbReference type="DOI" id="10.1093/intimm/dxl069"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="J. Clin. Endocrinol. Metab." volume="91" first="1056" last="1061">
<title>Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease.</title>
<authorList>
<person name="Simmonds M.J."/>
<person name="Heward J.M."/>
<person name="Carr-Smith J."/>
<person name="Foxall H."/>
<person name="Franklyn J.A."/>
<person name="Gough S.C.L."/>
</authorList>
<dbReference type="PubMed" id="16384851"/>
<dbReference type="DOI" id="10.1210/jc.2005-1634"/>
</citation>
<scope>INVOLVEMENT IN GRAVES DISEASE</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Ann. Rheum. Dis." volume="66" first="803" last="806">
<title>FCRL3 promoter 169 CC homozygosity is associated with susceptibility to rheumatoid arthritis in Dutch Caucasians.</title>
<authorList>
<person name="Thabet M.M."/>
<person name="Wesoly J."/>
<person name="Slagboom P.E."/>
<person name="Toes R.E.M."/>
<person name="Huizinga T.W.J."/>
</authorList>
<dbReference type="PubMed" id="17179172"/>
<dbReference type="DOI" id="10.1136/ard.2006.064949"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2007" name="Arthritis Rheum." volume="56" first="3168" last="3171">
<title>Meta-analysis evidence of a differential risk of the FCRL3 -169T--&gt;C polymorphism in white and East Asian rheumatoid arthritis patients.</title>
<authorList>
<person name="Begovich A.B."/>
<person name="Chang M."/>
<person name="Schrodi S.J."/>
</authorList>
<dbReference type="PubMed" id="17763442"/>
<dbReference type="DOI" id="10.1002/art.22857"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="1329" last="1337">
<title>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants.</title>
<authorList>
<consortium name="The Wellcome Trust case control consortium"/>
<consortium name="The Australo-Anglo-American spondylitis consortium"/>
</authorList>
<dbReference type="PubMed" id="17952073"/>
<dbReference type="DOI" id="10.1038/ng.2007.17"/>
</citation>
<scope>INVOLVEMENT IN GRAVES DISEASE</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="J. Immunol." volume="183" first="5502" last="5510">
<title>FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.</title>
<authorList>
<person name="Kochi Y."/>
<person name="Myouzen K."/>
<person name="Yamada R."/>
<person name="Suzuki A."/>
<person name="Kurosaki T."/>
<person name="Nakamura Y."/>
<person name="Yamamoto K."/>
</authorList>
<dbReference type="PubMed" id="19843936"/>
<dbReference type="DOI" id="10.4049/jimmunol.0901982"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH INPP5D; PTPN6; PTPN11; SYK AND ZAP70</scope>
<scope>PHOSPHORYLATION AT TYR-650; TYR-662; TYR-692 AND TYR-722</scope>
<scope>MUTAGENESIS OF TYR-650; TYR-662; TYR-692 AND TYR-722</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="J. Immunol." volume="182" first="7518" last="7526">
<title>Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells.</title>
<authorList>
<person name="Nagata S."/>
<person name="Ise T."/>
<person name="Pastan I."/>
</authorList>
<dbReference type="PubMed" id="19494275"/>
<dbReference type="DOI" id="10.4049/jimmunol.0802230"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Immunol." volume="184" first="3639" last="3647">
<title>Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.</title>
<authorList>
<person name="Swainson L.A."/>
<person name="Mold J.E."/>
<person name="Bajpai U.D."/>
<person name="McCune J.M."/>
</authorList>
<dbReference type="PubMed" id="20190142"/>
<dbReference type="DOI" id="10.4049/jimmunol.0903943"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2012" name="Arthritis Rheum." volume="64" first="2451" last="2459">
<title>A functional variant in FCRL3 is associated with higher Fc receptor-like 3 expression on T cell subsets and rheumatoid arthritis disease activity.</title>
<authorList>
<person name="Bajpai U.D."/>
<person name="Swainson L.A."/>
<person name="Mold J.E."/>
<person name="Graf J.D."/>
<person name="Imboden J.B."/>
<person name="McCune J.M."/>
</authorList>
<dbReference type="PubMed" id="22392608"/>
<dbReference type="DOI" id="10.1002/art.34457"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="Eur. J. Immunol." volume="43" first="2980" last="2992">
<title>FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.</title>
<authorList>
<person name="Li F.J."/>
<person name="Schreeder D.M."/>
<person name="Li R."/>
<person name="Wu J."/>
<person name="Davis R.S."/>
</authorList>
<dbReference type="PubMed" id="23857366"/>
<dbReference type="DOI" id="10.1002/eji.201243068"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2015" name="Int. J. Clin. Exp. Med." volume="8" first="16948" last="16954">
<title>Genetic associations of FCRL3 polymorphisms with the susceptibility of Graves ophthalmopathy in a Chinese population.</title>
<authorList>
<person name="Wu S."/>
<person name="Cai T."/>
<person name="Chen F."/>
<person name="He X."/>
<person name="Cui Z."/>
</authorList>
<dbReference type="PubMed" id="26629249"/>
</citation>
<scope>INVOLVEMENT IN GRAVES DISEASE</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2016" name="Hum. Immunol." volume="77" first="223" last="229">
<title>FCRL3 gene polymorphisms as risk factors for rheumatoid arthritis.</title>
<authorList>
<person name="Lin X."/>
<person name="Zhang Y."/>
<person name="Chen Q."/>
</authorList>
<dbReference type="PubMed" id="26746625"/>
<dbReference type="DOI" id="10.1016/j.humimm.2015.12.007"/>
</citation>
<scope>INVOLVEMENT IN RHEUMATOID ARTHRITIS</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2016" name="Mol. Neurobiol." volume="53" first="2029" last="2035">
<title>Four FCRL3 Gene Polymorphisms (FCRL3_3, _5, _6, _8) Confer Susceptibility to Multiple Sclerosis: Results from a Case-Control Study.</title>
<authorList>
<person name="Yuan M."/>
<person name="Wei L."/>
<person name="Zhou R."/>
<person name="Bai Q."/>
<person name="Wei Y."/>
<person name="Zhang W."/>
<person name="Huang Y."/>
</authorList>
<dbReference type="PubMed" id="25862376"/>
<dbReference type="DOI" id="10.1007/s12035-015-9149-7"/>
</citation>
<scope>INVOLVEMENT IN MULTIPLE SCLEROSIS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2006" name="Science" volume="314" first="268" last="274">
<title>The consensus coding sequences of human breast and colorectal cancers.</title>
<authorList>
<person name="Sjoeblom T."/>
<person name="Jones S."/>
<person name="Wood L.D."/>
<person name="Parsons D.W."/>
<person name="Lin J."/>
<person name="Barber T.D."/>
<person name="Mandelker D."/>
<person name="Leary R.J."/>
<person name="Ptak J."/>
<person name="Silliman N."/>
<person name="Szabo S."/>
<person name="Buckhaults P."/>
<person name="Farrell C."/>
<person name="Meeh P."/>
<person name="Markowitz S.D."/>
<person name="Willis J."/>
<person name="Dawson D."/>
<person name="Willson J.K.V."/>
<person name="Gazdar A.F."/>
<person name="Hartigan J."/>
<person name="Wu L."/>
<person name="Liu C."/>
<person name="Parmigiani G."/>
<person name="Park B.H."/>
<person name="Bachman K.E."/>
<person name="Papadopoulos N."/>
<person name="Vogelstein B."/>
<person name="Kinzler K.W."/>
<person name="Velculescu V.E."/>
</authorList>
<dbReference type="PubMed" id="16959974"/>
<dbReference type="DOI" id="10.1126/science.1133427"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] ASN-445</scope>
</reference>
<comment type="function">
<text evidence="17 18 19 21">Promotes TLR9-induced B-cell proliferation, activation and survival but inhibits antibody production and suppresses plasma cell differentiation. Enhances activation of NF-kappa-B and MAPK signaling pathways in TLR9 stimulated B-cells (PubMed:23857366). Has inhibitory potentional on B-cell receptor (BCR)-mediated signaling, possibly through association with SH2 domain-containing phosphatases. Inhibits cell tyrosine phosphorylation, calcium mobilization and activation-induced cell death induced through BCR signaling (PubMed:19843936). Regulatory T-cells expressing FCRL3 exhibit a memory phenotype, are relatively nonresponsive to antigenic stimulation in presence of IL2 and have reduced capacity to suppress the proliferation of effector T-cells (PubMed:20190142, PubMed:19494275).</text>
</comment>
<comment type="subunit">
<text evidence="5 18">Interacts (via phosphorylated ITIM motifs) with phosphatases INPP5D, PTPN6 and PTPN11. Interacts (via ITIM motifs) SYK and ZAP70.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-1754287">
<id>Q9NRZ5</id>
<label>AGPAT4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-11522780">
<id>Q96DZ9-2</id>
<label>CMTM5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-720480">
<id>P24593</id>
<label>IGFBP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-2808234">
<id>P11836</id>
<label>MS4A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-2825135">
<id>P22732</id>
<label>SLC2A5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-10294651">
<id>Q99726</id>
<label>SLC30A3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-17443171">
<id>Q96P31-6</id>
</interactant>
<interactant intactId="EBI-738687">
<id>P02808</id>
<label>STATH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="10 19">Cell membrane</location>
<topology evidence="10">Single-pass type I membrane protein</topology>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96P31-1</id>
<name>1</name>
<name>Spap2a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96P31-2</id>
<name>2</name>
<name>Spap2b</name>
<sequence type="described" ref="VSP_033300"/>
</isoform>
<isoform>
<id>Q96P31-3</id>
<name>3</name>
<name>Spap2c</name>
<sequence type="described" ref="VSP_033305"/>
</isoform>
<isoform>
<id>Q96P31-4</id>
<name>4</name>
<name>Spap2d</name>
<sequence type="described" ref="VSP_033301 VSP_033303"/>
</isoform>
<isoform>
<id>Q96P31-5</id>
<name>5</name>
<sequence type="described" ref="VSP_033302 VSP_033304"/>
</isoform>
<isoform>
<id>Q96P31-6</id>
<name>6</name>
<sequence type="described" ref="VSP_033308"/>
</isoform>
<isoform>
<id>Q96P31-7</id>
<name>7</name>
<sequence type="described" ref="VSP_033306 VSP_033307"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="3 4 5 6 10 19 21">Primarily expressed in secondary lymphoid tissues by mature subsets of B-cells. Low expression on transitional B cells which increases to higher surface expression on mature and memory B-cells with innate-like features (at protein level) (PubMed:23857366). Expressed a low levels in naive and germinal center B-cells but also expressed in NK cells (at protein level). Expressed in a population of thymically derived natrurally ocurring regulatory T-cells that exhibits a memory phenotype, specialized in suppressing immune response to self-antigens (PubMed:20190142). Detected in spleen, lymph node, peripheral blood lymphocytes, thymus, bone marrow, kidney, salivary gland, adrenal gland and uterus.</text>
</comment>
<comment type="developmental stage">
<text evidence="21">In B-cells, expression increases as a function of differentiation and peaks on memory B-cells.</text>
</comment>
<comment type="PTM">
<text evidence="5">Phosphorylated on cytoplasmic tyrosines; required for interaction with protein tyrosine phosphatases and protein tyrosine kinases.</text>
</comment>
<comment type="disease" evidence="6 7 9 11 13 14 15 20 24">
<disease id="DI-02692">
<name>Rheumatoid arthritis</name>
<acronym>RA</acronym>
<description>An inflammatory disease with autoimmune features and a complex genetic component. It primarily affects the joints and is characterized by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures.</description>
<dbReference type="MIM" id="180300"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<text evidence="6 8 16 22 23">Genetic variation in FCRL3 may influence susceptibility to autoimmune disorders, including Graves disease or multiple sclerosis. Graves disease is an autoimmune disorder associated with overactivity of the thyroid gland and hyperthyroidism. Multiple sclerosis is an autoimmune/inflammatory neurodegenerative disease which mainly affects young adults and is characterized by destruction of myelin in the central nervous system.</text>
</comment>
<dbReference type="EMBL" id="AY043466">
<property type="protein sequence ID" value="AAK91779.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF416901">
<property type="protein sequence ID" value="AAL13290.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF416902">
<property type="protein sequence ID" value="AAL13291.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF416903">
<property type="protein sequence ID" value="AAL13292.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF416904">
<property type="protein sequence ID" value="AAL13293.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF416905">
<property type="protein sequence ID" value="AAL13294.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF064732">
<property type="protein sequence ID" value="ABK41915.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK098122">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356276">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52872.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52876.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471121">
<property type="protein sequence ID" value="EAW52877.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028933">
<property type="protein sequence ID" value="AAH28933.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1167.1">
<molecule id="Q96P31-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS81385.1">
<molecule id="Q96P31-6"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001307262.1">
<molecule id="Q96P31-6"/>
<property type="nucleotide sequence ID" value="NM_001320333.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_443171.2">
<molecule id="Q96P31-1"/>
<property type="nucleotide sequence ID" value="NM_052939.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006711208.1">
<molecule id="Q96P31-1"/>
<property type="nucleotide sequence ID" value="XM_006711145.1"/>
</dbReference>
<dbReference type="BioGRID" id="125428">
<property type="interactions" value="13"/>
</dbReference>
<dbReference type="IntAct" id="Q96P31">
<property type="interactions" value="8"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000357167"/>
<dbReference type="GlyGen" id="Q96P31">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q96P31"/>
<dbReference type="PhosphoSitePlus" id="Q96P31"/>
<dbReference type="BioMuta" id="FCRL3"/>
<dbReference type="DMDM" id="74761021"/>
<dbReference type="MassIVE" id="Q96P31"/>
<dbReference type="PaxDb" id="Q96P31"/>
<dbReference type="PeptideAtlas" id="Q96P31"/>
<dbReference type="PRIDE" id="Q96P31"/>
<dbReference type="ProteomicsDB" id="77608">
<molecule id="Q96P31-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77609">
<molecule id="Q96P31-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77610">
<molecule id="Q96P31-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77611">
<molecule id="Q96P31-4"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77612">
<molecule id="Q96P31-5"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77613">
<molecule id="Q96P31-6"/>
</dbReference>
<dbReference type="ProteomicsDB" id="77614">
<molecule id="Q96P31-7"/>
</dbReference>
<dbReference type="Antibodypedia" id="2552">
<property type="antibodies" value="157 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="115352"/>
<dbReference type="Ensembl" id="ENST00000368184">
<molecule id="Q96P31-1"/>
<property type="protein sequence ID" value="ENSP00000357167"/>
<property type="gene ID" value="ENSG00000160856"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368186">
<molecule id="Q96P31-6"/>
<property type="protein sequence ID" value="ENSP00000357169"/>
<property type="gene ID" value="ENSG00000160856"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000477837">
<molecule id="Q96P31-2"/>
<property type="protein sequence ID" value="ENSP00000433430"/>
<property type="gene ID" value="ENSG00000160856"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000485028">
<molecule id="Q96P31-1"/>
<property type="protein sequence ID" value="ENSP00000434331"/>
<property type="gene ID" value="ENSG00000160856"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000492769">
<molecule id="Q96P31-3"/>
<property type="protein sequence ID" value="ENSP00000435487"/>
<property type="gene ID" value="ENSG00000160856"/>
</dbReference>
<dbReference type="GeneID" id="115352"/>
<dbReference type="KEGG" id="hsa:115352"/>
<dbReference type="UCSC" id="uc001fqz.5">
<molecule id="Q96P31-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="115352"/>
<dbReference type="DisGeNET" id="115352"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160856.20"/>
<dbReference type="GeneCards" id="FCRL3"/>
<dbReference type="HGNC" id="HGNC:18506">
<property type="gene designation" value="FCRL3"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160856">
<property type="expression patterns" value="Tissue enhanced (blood, lymphoid tissue)"/>
</dbReference>
<dbReference type="MIM" id="180300">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606510">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96P31"/>
<dbReference type="OpenTargets" id="ENSG00000160856"/>
<dbReference type="PharmGKB" id="PA142671767"/>
<dbReference type="eggNOG" id="ENOG502S65W">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT01000000214497"/>
<dbReference type="HOGENOM" id="CLU_023383_6_1_1"/>
<dbReference type="InParanoid" id="Q96P31"/>
<dbReference type="KO" id="K06727"/>
<dbReference type="OMA" id="PWSTTFK"/>
<dbReference type="OrthoDB" id="53940at2759"/>
<dbReference type="PhylomeDB" id="Q96P31"/>
<dbReference type="TreeFam" id="TF351107"/>
<dbReference type="PathwayCommons" id="Q96P31"/>
<dbReference type="BioGRID-ORCS" id="115352">
<property type="hits" value="4 hits in 863 CRISPR screens"/>
</dbReference>
<dbReference type="GeneWiki" id="FCRL3"/>
<dbReference type="GenomeRNAi" id="115352"/>
<dbReference type="Pharos" id="Q96P31">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q96P31"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q96P31">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160856">
<property type="expression patterns" value="Expressed in lymph node and 120 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q96P31">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96P31">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019900">
<property type="term" value="F:kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019902">
<property type="term" value="F:phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019903">
<property type="term" value="F:protein phosphatase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990782">
<property type="term" value="F:protein tyrosine kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007166">
<property type="term" value="P:cell surface receptor signaling pathway"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0050859">
<property type="term" value="P:negative regulation of B cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002638">
<property type="term" value="P:negative regulation of immunoglobulin production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030890">
<property type="term" value="P:positive regulation of B cell proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043410">
<property type="term" value="P:positive regulation of MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905184">
<property type="term" value="P:positive regulation of protein serine/threonine phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050864">
<property type="term" value="P:regulation of B cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045577">
<property type="term" value="P:regulation of B cell differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090279">
<property type="term" value="P:regulation of calcium ion import"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034163">
<property type="term" value="P:regulation of toll-like receptor 9 signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="2.60.40.10">
<property type="match status" value="6"/>
</dbReference>
<dbReference type="InterPro" id="IPR007110">
<property type="entry name" value="Ig-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036179">
<property type="entry name" value="Ig-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013783">
<property type="entry name" value="Ig-like_fold"/>
</dbReference>
<dbReference type="InterPro" id="IPR003599">
<property type="entry name" value="Ig_sub"/>
</dbReference>
<dbReference type="InterPro" id="IPR003598">
<property type="entry name" value="Ig_sub2"/>
</dbReference>
<dbReference type="InterPro" id="IPR013151">
<property type="entry name" value="Immunoglobulin"/>
</dbReference>
<dbReference type="Pfam" id="PF00047">
<property type="entry name" value="ig"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF13895">
<property type="entry name" value="Ig_2"/>
<property type="match status" value="4"/>
</dbReference>
<dbReference type="SMART" id="SM00409">
<property type="entry name" value="IG"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="SMART" id="SM00408">
<property type="entry name" value="IGc2"/>
<property type="match status" value="5"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48726">
<property type="entry name" value="SSF48726"/>
<property type="match status" value="6"/>
</dbReference>
<dbReference type="PROSITE" id="PS50835">
<property type="entry name" value="IG_LIKE"/>
<property type="match status" value="6"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0393">Immunoglobulin domain</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="1">
<location>
<begin position="1"/>
<end position="17"/>
</location>
</feature>
<feature type="chain" description="Fc receptor-like protein 3" id="PRO_0000331640">
<location>
<begin position="18"/>
<end position="734"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="1">
<location>
<begin position="18"/>
<end position="573"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="1">
<location>
<begin position="574"/>
<end position="594"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="1">
<location>
<begin position="595"/>
<end position="734"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 1">
<location>
<begin position="21"/>
<end position="98"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 2">
<location>
<begin position="99"/>
<end position="182"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 3">
<location>
<begin position="192"/>
<end position="270"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 4">
<location>
<begin position="284"/>
<end position="369"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 5">
<location>
<begin position="383"/>
<end position="470"/>
</location>
</feature>
<feature type="domain" description="Ig-like C2-type 6">
<location>
<begin position="476"/>
<end position="563"/>
</location>
</feature>
<feature type="short sequence motif" description="ITIM motif 1">
<location>
<begin position="648"/>
<end position="653"/>
</location>
</feature>
<feature type="short sequence motif" description="ITIM motif 2">
<location>
<begin position="660"/>
<end position="665"/>
</location>
</feature>
<feature type="short sequence motif" description="ITIM motif 3">
<location>
<begin position="690"/>
<end position="695"/>
</location>
</feature>
<feature type="short sequence motif" description="ITIM motif 4">
<location>
<begin position="720"/>
<end position="725"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="31">
<location>
<position position="650"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="31">
<location>
<position position="662"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="31">
<location>
<position position="692"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="31">
<location>
<position position="722"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="1">
<location>
<position position="561"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="44"/>
<end position="82"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="120"/>
<end position="163"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="211"/>
<end position="260"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="309"/>
<end position="358"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="404"/>
<end position="451"/>
</location>
</feature>
<feature type="disulfide bond" evidence="2">
<location>
<begin position="497"/>
<end position="544"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_033300" evidence="27">
<original>ELFLHPVLRASSSTPIEGSPMTLTCETQLSPQRPDVQLQFSLFRDSQTLGLGWSRSPRLQIPAMWTEDSGSYWCEVETVTHSIKKRSLRSQIRVQR</original>
<variation>G</variation>
<location>
<begin position="187"/>
<end position="282"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_033301" evidence="27">
<original>ELF</original>
<variation>GNG</variation>
<location>
<begin position="187"/>
<end position="189"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_033302" evidence="27">
<original>LFLHPVLRASSS</original>
<variation>ARCPAAILPLQR</variation>
<location>
<begin position="188"/>
<end position="199"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_033303" evidence="27">
<location>
<begin position="190"/>
<end position="734"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_033304" evidence="27">
<location>
<begin position="200"/>
<end position="734"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_033305" evidence="27">
<original>I</original>
<variation>TLLSPSV</variation>
<location>
<position position="378"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_033306" evidence="28">
<original>THPDDSAGEA</original>
<variation>EQSSRFSMSL</variation>
<location>
<begin position="698"/>
<end position="707"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 7." id="VSP_033307" evidence="28">
<location>
<begin position="708"/>
<end position="734"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 6." id="VSP_033308" evidence="29">
<original>VPRVLLASDH</original>
<variation>ILNPRKNKVQDFPCLCNT</variation>
<location>
<begin position="725"/>
<end position="734"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs7522061." id="VAR_042924" evidence="25 26">
<original>N</original>
<variation>D</variation>
<location>
<position position="28"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs12041673." id="VAR_042925">
<original>L</original>
<variation>F</variation>
<location>
<position position="307"/>
</location>
</feature>
<feature type="sequence variant" description="In a breast cancer sample; somatic mutation." id="VAR_042926" evidence="12">
<original>H</original>
<variation>N</variation>
<location>
<position position="445"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs944627." id="VAR_042927">
<original>P</original>
<variation>L</variation>
<location>
<position position="660"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2282284." id="VAR_042928">
<original>N</original>
<variation>S</variation>
<location>
<position position="721"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on inhibition of cell death. No effect on interaction with INPP5D, PTPN6 and PTPN11. Loss of phosphorylation, calcium influx inhibition and interaction with INPP5D, PTPN6 and PTPN11; when associated with F-662; F-692 and F-722. Alters binding with SYK and ZAP70; when associated with F-662. Decreases calcium influx inhibition; when associated with F-662 and F-722. Decreases calcium influx inhibition; when associated with F-692 and F-722." evidence="5 18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces inhibition of cell death. Decreases interaction with INPP5D and PTPN6. No effect on interaction with PTPN11. Loss of phosphorylation, calcium influx inhibition and interaction with INPP5D, PTPN6 and PTPN11; when associated with F-650; F-692 and F-722. Alters binding with SYK and ZAP70; when associated with F-650. Decreases calcium influx inhibition; when associated with F-650 and F-722. Increases calcium influx inhibition; when associated with F-650 and F-722." evidence="5 18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="662"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partially reduces inhibition of cell death. Decreases interaction with INPP5D and PTPN11. No effect on interaction with PTPN6. Loss of phosphorylation, calcium influx inhibition and interaction with INPP5D, PTPN6 and PTPN11; when associated with F-650; F-662 and F-722. Alters binding with PTPN6 and PTPN11; when associated with F-772. Decreases calcium influx inhibition; when associated with F-650 and F-722. Increases calcium influx inhibition; when associated with F-650 and F-662. Decreases calcium influx inhibition; when associated with F-722." evidence="5 18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="692"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on inhibition of cell death. No effect on interaction with INPP5D, PTPN6 and PTPN11. Loss of phosphorylation, calcium influx inhibition and interaction with INPP5D, PTPN6 and PTPN11; when associated with F-650; F-662 and F-692. Alters binding with PTPN6 and PTPN11; when associated with F-692. Decreases calcium influx inhibition; when associated with F-650 and F-662. Decreases calcium influx inhibition; when associated with F-650 and F-692. Decreases calcium influx inhibition; when associated with F-692." evidence="5 18">
<original>Y</original>
<variation>F</variation>
<location>
<position position="722"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AK098122." ref="4" evidence="30">
<original>R</original>
<variation>K</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAK91779." ref="1" evidence="30">
<original>V</original>
<variation>A</variation>
<location>
<position position="653"/>
</location>
</feature>
<evidence key="1" type="ECO:0000255"/>
<evidence key="2" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00114"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11493702"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11929751"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12051764"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15838509"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16176992"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16384851"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16476711"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16849395"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16859508"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16959974"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17133579"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17179172"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17763442"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17952073"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19494275"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19843936"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20190142"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22392608"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23857366"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25862376"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26629249"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26746625"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="26" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12051764"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000305"/>
<evidence key="31" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="19843936"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:18506"/>
</source>
</evidence>
<sequence length="734" mass="80856" checksum="B3411B73A35EC668" modified="2001-12-01" version="1" precursor="true">MLLWLLLLILTPGREQSGVAPKAVLLLNPPWSTAFKGEKVALICSSISHSLAQGDTYWYHDEKLLKIKHDKIQITEPGNYQCKTRGSSLSDAVHVEFSPDWLILQALHPVFEGDNVILRCQGKDNKNTHQKVYYKDGKQLPNSYNLEKITVNSVSRDNSKYHCTAYRKFYILDIEVTSKPLNIQVQELFLHPVLRASSSTPIEGSPMTLTCETQLSPQRPDVQLQFSLFRDSQTLGLGWSRSPRLQIPAMWTEDSGSYWCEVETVTHSIKKRSLRSQIRVQRVPVSNVNLEIRPTGGQLIEGENMVLICSVAQGSGTVTFSWHKEGRVRSLGRKTQRSLLAELHVLTVKESDAGRYYCAADNVHSPILSTWIRVTVRIPVSHPVLTFRAPRAHTVVGDLLELHCESLRGSPPILYRFYHEDVTLGNSSAPSGGGASFNLSLTAEHSGNYSCDADNGLGAQHSHGVSLRVTVPVSRPVLTLRAPGAQAVVGDLLELHCESLRGSFPILYWFYHEDDTLGNISAHSGGGASFNLSLTTEHSGNYSCEADNGLGAQHSKVVTLNVTGTSRNRTGLTAAGITGLVLSILVLAAAAALLHYARARRKPGGLSATGTSSHSPSECQEPSSSRPSRIDPQEPTHSKPLAPMELEPMYSNVNPGDSNPIYSQIWSIQHTKENSANCPMMHQEHEELTVLYSELKKTHPDDSAGEASSRGRAHEEDDEENYENVPRVLLASDH</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

